Henry Schein (HSIC) Cash from Financing Activities (2009 - 2026)
Henry Schein (HSIC) recorded quarterly Cash from Financing Activities of $120.0 million in Q1 2026, up 158.25% quarter-over-quarter from -$206.0 million in Q4 2025, and up 34.83% on a YoY basis from $89.0 million in Q1 2025.
Henry Schein (HSIC) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Henry Schein's Cash from Financing Activities history runs 18 years deep, the most recent figure standing at $120.0 million for Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 34.83% year-over-year to $120.0 million; the TTM figure through Mar 2026 stood at -$157.0 million (up 41.85% YoY), while the FY2025 annual figure was -$188.0 million, up 63.14% from the prior year.
- Cash from Financing Activities was $120.0 million for Q1 2026 at Henry Schein, up from -$206.0 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $394.0 million in Q4 2023 to a low of -$206.0 million in Q4 2025.
- Historically, Cash from Financing Activities has averaged -$11.3 million across 5 years, with a median of -$41.0 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities surged 303.09% in 2023, then slumped 819.05% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at -$194.0 million in 2022, then soared by 303.09% to $394.0 million in 2023, then slumped by 151.78% to -$204.0 million in 2024, then retreated by 0.98% to -$206.0 million in 2025, then jumped by 158.25% to $120.0 million in 2026.
- The last three Cash from Financing Activities figures came in at $120.0 million (Q1 2026), -$206.0 million (Q4 2025), and -$127.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | -2.82 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 3.98 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | -483.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 120.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 51.08 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -1.37 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 3.80 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 347,627.00 |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 120.00 Mn |
| Mar 28, 2026 | 120.00 Mn |
| Dec 27, 2025 | -206.00 Mn |
| Dec 27, 2025 | -206.00 Mn |
| Sep 27, 2025 | -127.00 Mn |
| Sep 27, 2025 | -127.00 Mn |
| Jun 28, 2025 | 56.00 Mn |
| Jun 28, 2025 | 56.00 Mn |
| Mar 29, 2025 | 89.00 Mn |
| Mar 29, 2025 | 89.00 Mn |
| Dec 28, 2024 | -204.00 Mn |
| Dec 28, 2024 | -204.00 Mn |
| Sep 28, 2024 | -41.00 Mn |
| Sep 28, 2024 | -41.00 Mn |
| Jun 29, 2024 | -114.00 Mn |
| Jun 29, 2024 | -114.00 Mn |
| Mar 30, 2024 | -151.00 Mn |
| Mar 30, 2024 | -151.00 Mn |
| Dec 30, 2023 | 394.00 Mn |
| Dec 30, 2023 | 394.00 Mn |